Health
As Trump Targets Researchers, Europe Makes a Pitch to Attract Scientists

As the Trump administration slashes support to research institutions and threatens to freeze federal funding to universities like Harvard and Columbia, European leaders are offering financial help to U.S.-based researchers and hoping to benefit from what they are calling a “gigantic miscalculation.”
“Nobody could imagine a few years ago that one of the great democracies of the world would eliminate research programs on the pretext that the word ‘diversity’ appeared in its program,” President Emmanuel Macron of France said on Monday.
He was speaking at the Sorbonne University in Paris during an event called Choose Europe for Science that was organized by the French government and the European Union.
It was unthinkable, Mr. Macron said, alluding also to the withdrawal of researchers’ visas in the United States, that a nation whose “economy depends so heavily on free science” would “commit such an error.”
Ursula von der Leyen, president of the European Commission, announced an investment of 500 million euros, or $566 million, at the conference to “make Europe a magnet for researchers” over the next two years.
Although that amount is not much compared to the billions in cuts American universities face, it comes on top of the $105 billion international research program called Horizon Europe that supports scientific breakthroughs, like genome sequencing and mRNA vaccines, Ms. Von der Leyen said.
She did not mention the United States by name, but she described a global environment where “fundamental, free and open research is questioned.”
“What a gigantic miscalculation!” she said.
In Europe, there is a widespread feeling that Mr. Trump has abandoned America’s traditional support for liberty, free speech and democracy through his embrace of autocrats and the assault on science and academia. That has created strains but also a sense of opportunity on the continent, where attracting the best scientific minds to vigorous and independent universities is seen as part of a broader campaign to “rearm” Europe as an independent power.
Over the longer term, the European Commission, the executive arm of the European Union, plans to double grants for researchers who relocate and to enshrine freedom of scientific research into a law called the European Research Area Act.
“The first priority is to ensure that science in Europe remains open and free. That is our calling card,” Ms. von der Leyen said.
The Trump administration’s attack on science and threats to universities were the main impetus for the conference, which was attended by government ministers and prominent researchers from across Europe. Increasingly, the United States is seen as a strategic adversary, and opening doors to American researchers and scientists is viewed as a long-term response to that challenge.
Mr. Macron’s message to scientists was this: “If you love freedom, come help us to remain free.”
France announced its own program to lure U.S.-based researchers last month. The government promised universities and research institutions in the country up to 50 percent of the funding needed to lure international researchers, including those working in areas under pressure from the Trump administration like climate studies and low carbon energy. But no particular funding was announced until Monday, when Mr. Macron said his government would commit $113 million to the program.
Alarms in Europe began sounding when the Trump administration slashed jobs and froze science grants at leading American institutions as part of cost-cutting measures. European dismay increased when the U.S. government attacked diversity programs and attempted to dictate to universities “whom they can admit and hire, and which areas of study and inquiry they can pursue,” in the words of Harvard’s president, Alan M. Garber.
Harvard has filed a lawsuit against the Trump administration over its $2.2 billion federal funding freeze. Mr. Trump mused last week about ending Harvard’s tax-exempt status.
The U.S. government has also fired staff at U.S. centers deemed to be at the pinnacle of scientific research, including at the National Oceanic and Atmospheric Administration, the National Science Foundation, the Centers for Disease Control and Prevention and the National Institutes of Health, the world’s largest funder of biomedical research.
At the same time, some federal agencies have removed words from websites and grant applications that were deemed unacceptable to the Trump administration. Among the terms considered taboo are “climate science,” “diversity” and “gender.”
Taken together, the actions have sent a chill through academia and research institutes, with scientists worried not just for their jobs but the long-term viability of their research.
“In the United States, once a paradise for researchers, academic freedom is being challenged. The line between truth and falsehood, between fact and belief, is being weakened,” Elisabeth Borne, France’s education minister, said Monday as she opened the conference.
Universities in France have been at the forefront of attempts to benefit from a potential American brain drain. Aix Marseille University is interviewing some 300 candidates for its Safe Place for Science program, which it launched in March in response to the Trump administration’s cuts. Since then, many other universities and institutions have followed suit.
“Our self-interest, as well as our values, now command us to be the refuge for knowledge wherever it is under pressure,” said Luis Vassy, the president of Sciences Po University in Paris.
François Hollande, a former French president, has proposed a law to create a “scientific refugee” status for researchers threatened for their work in their countries.
However, some university heads and professors have criticized the initiative. They argue that while France is attempting to draw American researchers, it has also been cutting higher education and research budgets to address the country’s ballooning budget deficit.

Health
Video: Trump Pushes Unproven Link Between Tylenol and Autism

new video loaded: Trump Pushes Unproven Link Between Tylenol and Autism
By Azeen Ghorayshi, Claire Hogan, Theodore Tae and June Kim•
Top U.S. health officials urged pregnant women not to use acetaminophen, the active ingredient in Tylenol, claiming it could cause autism, though studies have been inconclusive. Azeen Ghorayshi, a science reporter for The New York Times, explains.
Health
Autism by the numbers: Experts share reasons for the dramatic surge in diagnoses

NEWYou can now listen to Fox News articles!
Monday’s sweeping autism announcements have sparked deeper conversations about the widespread neurological disorder.
Health officials spoke during a press conference in Washington, D.C., about possible causes, vaccine guidance and the potential for a cancer drug to double as an autism therapy.
Autism diagnoses have been steadily rising in recent decades, according to the Centers for Disease Control and Prevention.
AUTISM SPECTRUM IN ADULTS HAS COMMONLY OVERLOOKED SYMPTOMS, EXPERTS WARN
“In the 1970s, autism was considered rare, perhaps 1 in 5,000 to 10,000 children,” Steven Quay, M.D., Ph.D., a physician-scientist and founder of Atossa Therapeutics in Seattle, Washington, told Fox News Digital.
In the year 2000, an estimated one in 150 children aged 8 had the disorder. By 2010, that number had risen to one in 68 — and by 2022, one in 31 children were diagnosed.
Autism diagnoses have been steadily rising in recent decades, according to the Centers for Disease Control and Prevention. (iStock)
“Autism is no longer an uncommon condition tucked away in psychiatric textbooks,” said Quay. “It is part of the daily fabric of schools, clinics and families everywhere.”
Dr. Aggie Papazyan, a Los Angeles-based psychologist specializing in autism spectrum disorder, noted that autism prevalence has also increased globally.
CANCER DRUG COULD DOUBLE AS AUTISM THERAPY, AND IS POISED FOR FDA APPROVAL
“These rates vary by region,” she told Fox News Digital. “In many places, especially in higher-income settings with more robust diagnostic and health resources, prevalence estimates have gone up.”
She added, “However, it’s important to note that how autism is measured makes a big difference.”
Awareness vs. epidemic
The CDC has noted that improved identification of autism could be part of the increase, but that other factors could also come into play.
Decades ago, many autistic people were “missed, misdiagnosed or labeled differently,” said Papazyan.
“There doesn’t seem to be a sudden surge in biological incidence.”
“Over time, as awareness has grown, diagnostic definitions expanded and screening became a bit more routine — so it’s not a surprise to see more autism diagnoses,” she said.
“The biggest misconception is that rising numbers mean autism itself is suddenly becoming more common,” the expert went on. “That’s scary to some people, but there’s no new autism ‘epidemic.’”

Experts say more funding is needed for early intervention programs, such as speech, occupational and behavioral therapies. (iStock)
Most of the increase, according to Papazyan, is due to earlier intervention, broader diagnostic criteria and improved access to services.
“There doesn’t seem to be a sudden surge in biological incidence,” she added. “There may still be a true rise, but it’s not as dramatic as many people want to think.”
Quay said it would be “naïve” to assume that the rise is due only to better detection, and said that environmental change also plays a role.
“Fifty years ago, many individuals on the spectrum were mislabeled — sometimes as intellectually disabled, sometimes as ‘eccentric’ or ‘odd,’ but I do not believe this accounts for the entire increase,” he said.

To counter the rising autism diagnoses, experts call for increasing awareness and acceptance while reducing stigma. (iStock)
“Environmental influences, from prenatal exposures to changes in maternal health to shifts in early childhood experiences, likely play some role.”
‘Urgent need’
To counter the rising autism diagnoses, Papazyan is calling for increasing awareness and acceptance while reducing stigma, as this affects how resources are allocated.
“Beyond that, we need to expand diagnostic and assessment services, especially in underserved communities, so that people are properly diagnosed and given the care they need,” she said.
Papazyan said more funding is also needed for early intervention programs, such as speech, occupational and behavioral therapies.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The experts also agreed that support is needed for autistic people as they get older, including mental health services, financial assistance and life skills development.
“Interventions are needed that go beyond childhood, because autistic adults will spend most of their lives outside the school system, yet services for them are almost nonexistent,” said Quay.
“Fifty years ago, many individuals on the spectrum were mislabeled.”
Looking ahead, Papazyan predicts that autism prevalence will continue to increase over the next few years before it slows down and eventually hits a plateau.
Quay also expects that prevalence will continue to rise in the near term, largely due to improvements in detection and “societal willingness to diagnose.”
For more Health articles, visit www.foxnews.com/health
“Whether there is a biological plateau remains to be seen,” he said. “If environmental contributors are identified and mitigated, we could see stabilization.”
Health
Who Makes Vaccine Policy Decisions in RFK Jr.’s Health Department?

For decades, as an activist, Robert F. Kennedy Jr. resisted the scientific consensus that vaccines are safe and necessary to prevent serious disease. Now at the helm of the nation’s health department, he has begun to put his extreme views into practice, ousting veteran scientists and installing allies across the nation’s health agencies to enact major shifts in vaccine policy.
Some of Mr. Kennedy’s hires are activists who have worked for years alongside him. Others are scientists who say they broadly support vaccines but publicly criticized Covid shots or mandates during the pandemic. Many of these scientists have begun to question the safety or value of other shots, reflecting the views of Mr. Kennedy. The following account is based on previous statements made by these officials and on interviews with current and former health agency leaders.
F.D.A. chief medical and scientific officer
Critical of Covid boosters and shots for healthy kids
F.D.A. commissioner
Skeptical of certain vaccines
Dr. Vinay Prasad
Dr. Marty Makary
The agency’s new vaccine lead and chief medical officer, Dr. Vinay Prasad, has called himself an “extreme pro-vaccine person,” and Dr. Marty Makary, the agency’s commissioner, said last week that “we believe in vaccines.”
But the two officials, who sharply criticized vaccine mandates as academic researchers during the pandemic, have expressed doubts about the safety and necessity of Covid boosters for healthy children and adults. This summer, Dr. Prasad overrode some agency scientists who favored widespread access to Covid shots, narrowing the vaccine’s eligibility to those 65 and older and to younger people with underlying medical conditions.
Last week, Dr. Makary echoed the views of Mr. Kennedy when he publicly questioned the longstanding recommendation to give the hepatitis B vaccine at birth. That shot is credited with nearly eliminating the transmission of the disease from mother to infant.
Dr. Prasad replaced a veteran at the agency, Dr. Peter Marks, who resigned in March and said that Mr. Kennedy’s aggressive stance on vaccines posed a danger to the public.
In June, Mr. Kennedy fired all 17 members of a powerful C.D.C. expert panel, the Advisory Committee on Immunization Practices. Insurance companies and government programs like Medicaid are required to cover the vaccinations that the panel recommends.
Mr. Kennedy handpicked eight new members that month, half of whom had expressed skepticism of vaccines at some point. (One has since stepped down.) Others have little expertise in immunology or vaccines.
On Monday, Mr. Kennedy appointed five more members, just days before the group meets to review recommendations for multiple vaccines. Some of the newly selected members have been critical of Covid vaccines or vaccine mandates.
Dr. Robert Malone is a controversial figure. He performed early experiments using mRNA in the 1980s but gained notoriety during the pandemic for claiming that Covid vaccines were unsafe, contradicting volumes of studies.
Martin Kulldorff, a biostatistician, has been generally supportive of vaccines but opposed Covid vaccination for children and vaccine mandates. Vicky Pebsworth, a nurse with a doctorate in public health, serves on the board of the National Vaccine Information Center, a nonprofit that disseminates misinformation about the risks of vaccination.
Dr. Malone and Dr. Kulldorff have served as paid expert witnesses in legal cases against vaccine makers. Dr. Pebsworth claimed in a lawsuit that a survey of families of unvaccinated children supported a hypothesis that a rise in the number of recommended childhood vaccines explained an epidemic of chronic disease.
Another panel member, Retsef Levi, is a management and health analytics expert at the Massachusetts Institute of Technology. He has been critical of a variety of vaccines and has called for Covid vaccines to be pulled from the market.
Dr. Evelyn Griffin, an obstetrician and gynecologist, questioned the safety and effectiveness of Covid vaccines in a hearing in the Louisiana House of Representatives in 2021. Dr. Kirk Milhoan, a pediatric cardiologist, questioned the safety and effectiveness of Covid vaccines at a 2024 event led by Representative Marjorie Taylor Greene, Republican of Georgia. Catherine M. Stein is an epidemiology professor who in 2022 called for an end to Covid vaccine mandates at universities.
Dr. Cody Meissner is a professor of pediatrics who opposed vaccine mandates and has questioned the ongoing need for Covid vaccines for children and pregnant women. He previously served on the advisory committee and is widely considered to be the most qualified member.
The others are not known to have spoken out against vaccines. They are Dr. Joseph R. Hibbeln, a nutritional neuroscientist; Dr. James Pagano, an emergency medicine physician; Hillary Blackburn, a pharmacist; and Dr. Raymond Pollak, a surgeon and transplant specialist.
The C.D.C. director has the power to accept or reject the immunization committee’s recommendations. The current acting director is Mr. Kennedy’s deputy at the Department of Health and Human Services, Jim O’Neill, a former biotechnology executive. The previous director, Susan Monarez, said she was forced out because she would not agree to accept the newly re-formed committee’s recommendations.
A special adviser to the C.D.C. director, Stuart Burns, is a critical player driving the health secretary’s agenda at the agency. Mr. Burns has been quietly working to remake the immunization committee and its agenda.
Mr. Burns is not a scientist but he worked for decades as a staff member for Republican congressmen known for their vaccine skepticism. One is Dr. Dave Weldon, a former representative from Florida who was also Mr. Kennedy’s original choice for C.D.C. director. The White House withdrew Dr. Weldon’s nomination just hours before his confirmation hearing because some Senate Republicans were concerned about his stance on vaccines.
Mr. Burns works closely with three other Kennedy hires who serve H.H.S. but also work closely with the C.D.C. Dr. Reyn Archer is a former Texas health commissioner who has questioned the safety and value of the Covid vaccine on social media. He serves as a liaison between the health secretary’s office and the C.D.C., and has been helping Mr. Burns to develop and guide the immunization committee.
David Geier is a steadfast figure in the anti-vaccine movement who has spent more than 20 years trying to establish a link between vaccines and autism, despite scientific consensus that there is none. Mr. Geier, who is listed as a senior data analyst in the H.H.S. directory, was given access to federal data on post-vaccination side effects and is using it to continue his studies on autism.
Lyn Redwood is a nurse practitioner and the former head of Children’s Health Defense, the anti-vaccine group founded by Mr. Kennedy. Since the early 2000s, Ms. Redwood has criticized the use of mercury as a preservative in vaccines. She has said she believes the ingredient is linked to her son’s autism.
Now listed as an expert at H.H.S., Ms. Redwood gave a presentation in June to the immunization committee, a role usually reserved for C.D.C. scientists. She said that the mercury preservative in vaccines, known as thimerosal, was toxic to children, even though dozens of studies have shown it is harmless in this form. The panel later voted to stop recommending the already limited number of flu vaccines that contained the preservative.
Principal deputy director of the N.I.H.
Skeptical of certain vaccines
N.I.H. director
Critical of Covid vaccine mandates
Dr. Matthew Memoli
Dr. Jay Bhattacharya
Dr. Matthew Memoli is a veteran infectious disease scientist at the National Institutes of Health who now serves as its principal deputy director. As a senior researcher under Dr. Anthony Fauci during the pandemic, Dr. Memoli opposed Covid vaccine mandates and declined to get a shot himself.
Since becoming a leader of the research agency, Dr. Memoli has downplayed the value of vaccines for certain respiratory diseases, according to the whistle-blower complaints of two prominent scientists.
Dr. Jay Bhattacharya, the N.I.H director, sharply criticized vaccine mandates as an academic researcher during the pandemic. He co-wrote an anti-lockdown treatise in 2020 with Dr. Kulldorff, one of Mr. Kennedy’s selections for the C.D.C. immunization committee.
During his confirmation hearing in March, Dr. Bhattacharya reiterated his support for childhood vaccinations for diseases like measles. He also said he was “convinced” vaccines did not cause autism, even as he urged more research on the question, which scientists say has long been settled.
-
Finance5 days ago
Reimagining Finance: Derek Kudsee on Coda’s AI-Powered Future
-
Business1 week ago
How Nexstar’s Proposed TV Merger Is Tied to Jimmy Kimmel’s Suspension
-
North Dakota5 days ago
Board approves Brent Sanford as new ‘commissioner’ of North Dakota University System
-
World1 week ago
Russian jets enter Estonia's airspace in latest test for NATO
-
Crypto4 days ago
Texas brothers charged in cryptocurrency kidnapping, robbery in MN
-
World4 days ago
Syria’s new president takes center stage at UNGA as concerns linger over terrorist past
-
Technology4 days ago
These earbuds include a tiny wired microphone you can hold
-
Culture4 days ago
Test Your Memory of These Classic Books for Young Readers